RSA expands global network
pharmafile | February 11, 2010 | Appointment | Business Services |Â Â appointment, business services, rsaÂ
RSA has made a series of new appointments across its global network with new starters in the UK, Germany, US and Singapore.
Rob Sansom (pictured) has joined the UK sales and marketing team, bringing to the company over five years of pharmaceutical and life sciences recruitment expertise.
He started his career as a medical sales representative working for an ethical pharmaceutical company and since then has developed a track record of placing candidates from director level to physician appointments.
Outside the UK, RSA Germany has appointed Daniel Braun and Serina Weston.
Daniel joins the company from Progressive Recruitment in Munich, and in his new role will be responsible for growing RSA’s interim management market in South Germany and Austria.
Serina Weston joins RSA Germany as a trainee researcher and previously worked in the German internet industry as a key account manager for online job portal CareerBuilder.
In the US, Nick LiBassi comes to RSA as a recruiting consultant with over 15 years of broad professional sales experience. Most recently, Nick was in charge of a national sales team launching new products on behalf of consumer health specialists Johnson & Johnson.
Also in the US Jennifer Han joins the company as office manager.
Finally, Kamini Nair recently joined RSA Singapore as a researcher, having previously held a position at international recruitment specialist Beresford Blake Thomas.
RSA’s chief executive Nick Stephens said: “It is a pleasure to welcome in the New Year with such dynamic and ambitious new members of staff.
“We trust that they will find that RSA offers them the chance to expand upon previous experience and inject new ideas and enthusiasm into their roles.”
Related Content
Astellas selects Veeva Vault CRM as global commercial platform
Astellas has selected Veeva Vault CRM as its global customer relationship management (CRM) platform, with …
David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
